(Q44350368)

2 December 2017

Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions (English)

1 reference

2 December 2017

0 references

Crain SM

1

1 reference

PubMed ID

9786023

2 December 2017

Shen KF

series ordinal

2

1 reference

PubMed ID

9786023

2 December 2017

language of work or name

1 reference

1 September 1998

1 reference

Trends in Pharmacological Sciences

2 December 2017

1 reference

2 December 2017

19

1 reference

2 December 2017

9

1 reference

2 December 2017

358-365

1 reference

Gangliosides as Receptor Modulators

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

The stimulatory effects of opioids and their possible role in the development of tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Stimulatory effects of opioids on transmitter release and possible cellular mechanisms: overview and original results

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by Gs-linked opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Cholera toxin-B subunit blocks excitatory effects of opioids on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Nerve growth factor rapidly prolongs the action potential of mature sensory ganglion neurons in culture, and this effect requires activation of Gs-coupled excitatory kappa-opioid receptors on these cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Inhibition of the antianalgesic action of dynorphin A in mice by cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid 'dependence' without tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Chronic morphine-treated sensory ganglion neurons remain supersensitive to the excitatory effects of naloxone for months after return to normal culture medium: an in vitro model of 'protracted opioid dependence'.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

An opiate-receptor gene family reunion.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Opioid receptor types and subtypes: the delta receptor as a model.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Interaction of the delta-opioid receptor with GM1 ganglioside: conversion from inhibitory to excitatory mode

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

The role of GM1 ganglioside in regulating excitatory opioid effects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Differential opioid agonist regulation of the mouse mu opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Chronic opioid treatment of neuroblastoma x dorsal root ganglion neuron hybrid F11 cells results in elevated GM1 ganglioside and cyclic adenosine monophosphate levels and onset of naloxone-evoked decreases in membrane K+ currents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Brief treatment of sensory ganglion neurons with GM1 ganglioside enhances the efficacy of opioid excitatory effects on the action potential

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

GM1 ganglioside-induced modulation of opioid receptor-mediated functions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Possible role of gangliosides in regulating an adenylate cyclase-linked 5-hydroxytryptamine (5-HT1) receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

GM1 ganglioside modulates prostaglandin E1 stimulated adenylyl cyclase in neuro-2A cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Opioids at low concentration decrease openings of K+ channels in sensory ganglion neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Single potassium channels opened by opioids in rat locus ceruleus neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Dual regulation by mu, delta and kappa opioid receptor agonists of K+ conductance of DRG neurons and neuroblastoma X DRG neuron hybrid F11 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Biphalin, an enkephalin analog with unexpectedly high antinociceptive potency and low dependence liability in vivo, selectively antagonizes excitatory opioid receptor functions of sensory neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Actions of etorphine hydrochloride, (M99): a potent morphine-like agent

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Differential agonist regulation of the human kappa-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Structure and expression of novel spliced leader RNA genes in Caenorhabditis elegans.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Protein kinase C involvement in homologous desensitization of delta-opioid receptor coupled to Gi1-phospholipase C activation in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Chronic morphine administration increases beta-adrenergic receptor kinase (beta ARK) levels in the rat locus coeruleus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Modulation of adenylate cyclase activity of mouse spinal cord-ganglion explants by opioids, serotonin and pertussis toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Direct demonstration of the activation of UDP-N-acetylgalactosamine: [GM3]N-acetylgalactosaminyltransferase by cyclic AMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Intracerebroventricular injection of antibodies directed against Gs alpha enhances the supraspinal antinociception induced by morphine, beta-endorphin and clonidine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

The development of morphine tolerance and dependence is associated with translocation of protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Where is the locus in opioid withdrawal?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

Reinforcement processes in opiate addiction: a homeostatic model

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901241-3

7 January 2021

10.1016/S0165-6147(98)01241-3

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

9786023